News

Thumbnail

First-in-human data suggest the therapy, CTX310, could be a breakthrough for patients with lipid disorders.

artificial intelligence AI heart cardiology

Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well. 

Stereotaxis GenesisX

GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

Sahil Parikh, MD, director of endovascular services, Columbia University Irving Medical Center, associate professor of medicine at Columbia University, and a program director for the Transcatheter Cardiovascular Therapeutics (TCT) meeting, explains the growing focus in interventional cardiology on endovascular procedures for stroke, pulmonary embolism, peripheral artery disease and renal denervation.

Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.

Robert H. Bartlett, MD

Robert H. Bartlett, MD, was a pioneer surgeon who helped develop the world's first ECMO technology. He died at the age of 86 following a long illness. 

HeartFlow Plaque Analysis Example

Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.

Thumbnail

The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine. 

pharmaceutical drug approval process

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 

Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.

Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success. 

The new analysis included data from more than 126,000 vaccinations. 

Thumbnail

Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes. 

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.